Treatment Approach Used In Cancer Holds Promise For Alzheimer’s Disease
A few talented researchers have developed a unique treatment which could block the development of the Alzheimer's disease using tiny drops of fat to carry the drugs into the brain. This treatment was aimed to carry drugs to the cancer cells. But, now, it has been successfully applied to block the expansion of Alzheimer's disease. It was initially tested in mice by restoring their lost memory.
The study was carried out by the researchers of the Lancaster University and was sponsored by Alzheimer's Society. It was published in the journal named 'Nanomedicine: Nanotechnology, Biology, and Medicine'. The treatment used tiny drops of fat called 'Nanoliposomes', which are covered in protein fragments. These fragments can prevent the amyloid protein accumulation in the plaques. Amyloid plaques are poisonous clusters of proteins.
The mice were injected with nanoliposomes for three weeks. Mice that perceived the drug recovered their long term memory and could recognize the informed objects after a 24-hour period. Whereas, mice that perceived an injection did not remember the objects which were shown to them previously.
According to a report published by Medical News Today, Professor David Allsop, a lead researcher, said, "There is a renewed confidence for antibody drugs, a treatment that can fasten the defense compliment of the body to aim the amyloid plaques. If it concludes successfully, the treatments will have to be administered in a hospital by an IV session and could have some potentially damaging side effects."
Nanoliposomes are generally used to improve the poisonous chemotherapy drugs to cancer cells. As per a study published by the Science Daily, recent studies have shown that a drop of fat can pass directly into the mind through the nose, open adults a probability of controlling a nasal mist to discharge the treatments for mind disease, such as Alzheimer's.
Nanotechnology is offering great benefits to people with various types of cancer. There are nearly 8, 50,000 people in the UK who are living with dementia. The drugs available at present can only treat the symptoms of dementia.